Aredia and Sutent drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Aredia (pamidronate disodium) and Sutent (sunitinib malate). Common drug interactions include adrenal insufficiency among females and pain in extremity among males.

The phase IV clinical study analyzes what interactions people have when they take Aredia and Sutent. It is created by eHealthMe based on reports of 44 people who take the same drugs from the FDA, and is updated regularly.

What is Aredia?

Aredia has active ingredients of pamidronate disodium. It is often used in breast cancer. eHealthMe is studying from 15,364 Aredia users. Check the latest studies of Aredia.

What is Sutent?

Sutent has active ingredients of sunitinib malate. It is often used in renal cell carcinoma. eHealthMe is studying from 44,554 Sutent users. Check the latest studies of Sutent.

On Jul, 27, 2026

44 people who take Aredia and Sutent together, and have interactions are studied.

What are the common drug interactions of Aredia and Sutent, by gender? *:

female:

Adrenal insufficiency (a condition in which the adrenal glands do not produce adequate amounts of steroids)
Dehydration (dryness resulting from the removal of water)
Anaemia (lack of blood)
Fatigue (feeling of tiredness)
Cerebellar infarction (impaired blood circulation to cerebellum)
Diarrhoea
Disease progression
Hyperkalaemia (damage to or disease of the kidney)
Anxiety
Atelectasis (partial or complete collapse of the lung)

male:

Pain in extremity
Arthralgia (joint pain)
Nausea (feeling of having an urge to vomit)
Osteonecrosis of jaw (death of bone of jaw)
Dermatitis (inflammation of the skin resulting from direct irritation by an external agent or an allergic reaction to it)
White blood cell count decreased
Death
Skin exfoliation (removal of the oldest dead skin cells)
Weight decreased
Blister (small pocket of fluid within the upper layers of the skin caused by forceful rubbing (friction), burning, freezing, chemical exposure)

What are the common drug interactions of Aredia and Sutent, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

Dehydration (dryness resulting from the removal of water)
Disease progression
Dizziness
Dysgeusia (disorder of the sense of taste)
Pneumonia
Blood creatinine increased
Bursitis (inflammation of a bursa, typically one in the knee, elbow, or shoulder)
Capillary leak syndrome (capillary leaks plasma)
Neoplasm malignant (cancer tumour)
Pain in jaw

60+:

Decreased appetite
White blood cell count decreased
Blood creatinine increased
Blood pressure increased
Cerebellar infarction (impaired blood circulation to cerebellum)
Joint swelling
Pain
Pain in extremity
Weight decreased
Abdominal distension

What are the existing conditions these people have? *

Renal Cell Carcinoma Stage Unspecified (kidney cancer in unknown stage): 10 people, 22.73%
Pain: 9 people, 20.45%
Metastatic Renal Cell Carcinoma (spreadable kidney cell tumour): 8 people, 18.18%
Bone Lesion (bone with abnormalities. bone lesions can result from growth formations, infections, or injuries): 7 people, 15.91%
High Blood Pressure: 6 people, 13.64%
Metastases To Bone (cancer spreads to bone): 5 people, 11.36%
Pain In Extremity: 3 people, 6.82%
Osteoporosis (bones weak and more likely to break): 3 people, 6.82%
Nausea (feeling of having an urge to vomit): 3 people, 6.82%
Hypercalcaemia (elevated calcium (ca+) level in the blood): 3 people, 6.82%

* Approximation only. Some reports may have incomplete information.

Do you take Aredia and Sutent?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously